一名身着海军服和浅蓝色衬衫的男子对着镜头微笑,背景是一个模糊的公司法律办公室。

布莱恩-C-惠勒

合作伙伴

布莱恩-C-惠勒

合作伙伴

Brian Wheeler is a seasoned strategic advisor with decades of experience providing legal and business guidance to clients across a wide variety of industries. Both Brian’s work in private practice and his in-house career have given him an extensive background in M&A —particularly cross-border M&A — transactions involving venture-backed companies in the technology and life sciences sectors, growth equity, private equity, and fund structuring.

Brian’s legal acumen extends beyond private practice to his significant in-house tenure at companies on the cutting-edge of the technological revolution. The former general counsel and head of corporate development of Heni, an international technology and art services company, Brian spent five years at SoftBank Investment Advisers, where as managing partner and general counsel he was involved in all aspects of the firm’s formation, expansion, operations, and management, particularly with regards to fund formation, fundraising, fund regulatory matters, and LP relations. At Softbank, Brian led a global team to design a structure for the Softbank Vision Fund, the world’s largest technology-focused investment fund at over US$130bn in invested capital, and managed the fundraising, investing, and compliance functions for the fund.

Prior to moving in-house, Brian was a partner at a global law firm in its Palo Alto office. Proficient in Japanese, Brian previously practiced in Tokyo for seven years and in London for four years.

代表经验

  • Represented General Catalyst in Local Kitchen’s Series C Preferred Stock Financing and recapitalization
  • Represented a venture capital firm in its investment in Exo Imaging, Inc.’s Series D financing
  • Represented Samsung Ventures in it’s investment in NinjaTech AI, Inc.
  • Represented Samsung Ventures as an investor in the $64 million Series A funding round for Cartesia AI
  • Represented a venture firm in its participation in Icon Technology, Inc’s Series C financing
  • Represented a computer parts manufacturer in its LP investment in Alchemist Accelerator Fund III
  • Represented TCG Crossover (TCGX) as lead investor in $105m Series B round into Pathalys Pharma, Inc
  • Represented NASDAQ-listed Move, Inc., operator of realtor.com, in its US$995 million sale to News Corporation*
  • Represented ProteinSimple in its US$300 million sale to Techne Corporation*
  • Represented CardioKinetix in its US$50 million financing and entry into a merger option agreement granting Edwards Lifesciences Corporation the right to acquire the company*
  • Represented Kik Interactive, Inc. in its acquisition of Endemic Mobile, developer of the Relay GIF messaging app*
  • Represented Paratek Pharmaceuticals in its acquisition of NASDAQ-listed Transcept Pharmaceuticals and its related US$93 million financing*
  • Represented Jaspersoft in its US$185 million sale to TIBCO Software, Inc*
  • Represented Griffin Holdings LLC in its acquisition of NASDAQ-listed Tufco Technologies, Inc*
  • Represented Jazz Pharmaceuticals in its acquisition of the rights to ADX-NO5 from Aerial BioPharma*
  • Represented Brocade Communications in the sale of its adapter and mezzanine card business to Qlogic Corporation*
  • Represented NextBio in its sale to Illumina, Inc*
  • Represented Simcere Pharmaceutical Holding in a broad-ranging strategic partnership with Merck & Co., Inc. for the sale and potential manufacturing of medicines in China, including the establishment of an equity joint venture and the co-marketing and co-promotion of various Merck- and Simcere-branded medicines*
  • Represented FUJIFILM Holdings Corporation in its US$995 million acquisition of NASDAQ-listed SonoSite, Inc*
  • Represented the special committee of the board of directors of China Real Estate Information Corporation in its US$278 million acquisition by its majority shareholder E-House (China) Holdings Limited*
  • Represented SINA Corporation in connection with its investments in Tudou Holdings Limited and E-House (China) Holdings Limited and various other general corporate matters*
  • Represented Shiseido Company, Limited in its US$1.7 billion acquisition of NASDAQ-listed Bare Escentuals, Inc*
  • Represented Mizuho Corporate Bank, Ltd. in its acquisition of Banco WestLB do Brasil S.A. from WestLB AG; its US$120 million investment in and strategic alliance with Evercore Partners Inc.; and its US$1.2 billion investment in Merrill Lynch & Co., Inc*
  • Represented Goldman Sachs Principal Investments Area in investments in a PRC-based media company and a Korean pharmaceutical company*
  • Represented The Longreach Group in its US$694 million acquisition of a 51 percent interest in EnTie Commercial Bank, Ltd*

* 加入 Foley 之前处理的事务。

Community Engagement

  • Advisory Board Member, Women in Business Law Initiative, University of California, Berkeley School of Law, 2018-2021
  • Board of Managers, Stonestown Family YMCA

语言

  • Japanese
December 8, 2025 Foley Viewpoints

2026 Outlook: AI, IPOs, and the New “Normal” in Venture & Private Equity

Key Takeaways The 2026 outlook for market activity is cautiously optimistic amid ongoing challenges.Private equity firms are shifting to...
2025 年 11 月 5 日 新闻

Louis Lehot 和 Brian Wheeler 发布私募股权流动性趋势分析报告

Foley & Lardner LLP 合伙人路易斯-雷霍特(Louis Lehot)和布莱恩-惠勒(Brian Wheeler)撰写了题为 "私募股权投资的新流动性玩法:创意现在可与资本相媲美 "的文章,发表在《全球金融家》杂志 2025 年 12 月刊上。
抽象数字艺术作品以蓝色发光点和线条为特色,在深蓝色背景上形成起伏的波浪图案,让人联想到企业法律办公室中常见的动态能量。
2025 年 11 月 4 日 福里点燃

2025 年第三季度美国私募股权投资市场展望

进入 2026 年的最后冲刺阶段,空气中弥漫着一种乐观情绪。美联储终于发布了我们期待已久的首次降息,我们也看到首次公开募股(IPO)方面的一系列活动,以及并购(M&A)活动的回暖。
August 18, 2025 Foley Ignite

Japan’s M&A Boom: A Private Equity Powerhouse in 2025

Mergers and acquisitions in Japan have been going against the global trend, which is leading to dealmakers taking a closer look at...
July 11, 2025 Deals and Wins

Foley Represents Sorcero in Strategic Acquisition of Axiom Health

Foley & Lardner LLP represented Sorcero in its strategic acquisition of Axiom Health, a medtech DaaS (data-as-a-service) company. This marks a pivotal expansion for Sorcero into the medical device market and expands the company’s product suite to include market and product intelligence.
2025 年 6 月 20 日 新闻

布莱恩-惠勒和莱曼-泰评论私募股权投资进入小众体育领域

Foley & Lardner LLP 合伙人 Brian Wheeler 和 Lyman Thai 在《养老金与投资》(Pensions & Investments)杂志的文章 "Ares Management 收购法国帆船队少数股权 "中描述了私募股权投资在小众体育领域不断增长的投资。